PIK3CA RELATED OVERGROWTH SPECTRUM
Clinical trials for PIK3CA RELATED OVERGROWTH SPECTRUM explained in plain language.
Never miss a new study
Get alerted when new PIK3CA RELATED OVERGROWTH SPECTRUM trials appear
Sign up with your email to follow new studies for PIK3CA RELATED OVERGROWTH SPECTRUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare blood vessel disorders: targeted drugs enter trial
Disease control Recruiting nowThis study tests two targeted drugs for people with vascular malformations (abnormal blood or lymph vessels). Participants with slow-flow malformations and a specific gene mutation receive alpelisib, while those with fast-flow malformations and another mutation receive mirdametin…
Matched conditions: PIK3CA RELATED OVERGROWTH SPECTRUM
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Scientists seek clues to rare overgrowth condition
Knowledge-focused Recruiting nowThis study aims to learn more about Proteus syndrome, a rare condition causing abnormal growth of bones, skin, and other tissues. Researchers will examine up to 1,500 participants to find the genetic causes and track how the disease changes over time. Participants undergo physica…
Matched conditions: PIK3CA RELATED OVERGROWTH SPECTRUM
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated May 26, 2026 07:26 UTC